A Multicountry, Multicentre, Non-interventional, Retrospective Study to determine Real-world treatment patterns and associated outcomes after First Line Osimertinib in patients with advanced and Metastatic NSCLC EGFRm in the GCC Region

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Kuwait	Kuwait, Kuwait
Qatar	Doha, Qatar
Saudi Arabia	Dammam, Saudi Arabia
Saudi Arabia	Jeddah, Saudi Arabia
Saudi Arabia	Riyadh, Saudi Arabia
United Arab Emirates	Abu Dhabi, United Arab Emirates
United Arab Emirates	Al Ain, United Arab Emirates